Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
A. Fasano, C. Catassi.
Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum.
Gastroenterology, 120 (2001), pp. 636-651
[2.]
S. Bevan, S. Popat, C.P. Braegger, A. Busch, D. O'Donoghue, K. Falth-Magnusson, et al.
Contribution of the MHC region to the familial risk of celiac disease.
J Med Genet, 36 (1999), pp. 687-690
[3.]
L. Greco, R. Romino, I. Coto, N. Di Cosmo, S. Percopo, M. Maglio, et al.
The first large population based twin study of coeliac disease.
Gut, 50 (2002), pp. 624-628
[4.]
L.M. Sollid, G. Markussen, J. Ek, H. Gjerde, F. Vartdal, E. Thorsby.
Evidence for a primary association of celiac disease to a particular HLA-DQα/β heterodimer.
J Exp Med, 169 (1989), pp. 345-350
[5.]
L.M. Sollid, E. Thorsby.
HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis.
Gastroenterology, 105 (1993), pp. 910-922
[6.]
A. Spurkland, L.M. Sollid, I. Polanco, F. Vartdal, E. Thorsby.
HLA-DR and DQ genotypes of celiac disease patients serologically typed to be non-DR3 or non- DR5/7.
Hum Immunol, 35 (1992), pp. 188-192
[7.]
K. Karell, A.S. Louka, S.J. Moodie, H. Ascher, F. Clerget-Darpoux, L. Greco, et al.
HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Coeliac Disease.
Hum Immunol, 64 (2003), pp. 469-477
[8.]
A. Polvi, E. Arranz, M. Fernandez-Arquero, P. Collin, M. Maki, A. Sanz, et al.
HLA-DQ2-negative celiac disease in Finland and Spain.
Hum Immunol, 59 (1998), pp. 169-175
[9.]
R. Ploski, J. Ek, E. Thorsby, L.M. Sollid.
On the HLA-DQ(alpha 1*0501, beta 1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201.
Tissue Antigens, 41 (1993), pp. 173-177
[10.]
E. Arranz, J.J. Telleria, A. Sanz, J.F. Martin, M. Alonso, C. Calvo, et al.
HLADQA1* 0501 and DQB1*02 homozygosity and disease susceptibility in Spanish coeliac patients.
Exp Clin Immunogenet, 14 (1997), pp. 286-290
[11.]
F. Clot, C. Gianfrani, M.-.C. Babron, F. Bouguerra, S. Southwood, M.F. Kagnoff, et al.
HLA-DR53 molecules are associated with susceptibility to celiac disease and selectively bind gliadin-derived peptides.
Immunogenetics, 49 (1999), pp. 800-807
[12.]
J.A. Garrote, E. Arranz, A. Blanco-Quiros.
The HLA-DRB4 gene is present in half of the Spanish HLA-DQ2-negative celiac patients.
Immunogenetics, 51 (2000), pp. 1045-1046
[13.]
O. Molberg, S.N. McAdam, R. Korner, H. Quarsten, C. Kristiansen, L. Madsen, et al.
Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease.
Nat Med, 4 (1998), pp. 713-717
[14.]
L.M. Sollid.
Coeliac disease: dissecting a complex inflammatory disorder.
Nature Rev, 2 (2002), pp. 647-654
[15.]
A.S. Louka, L.M. Sollid.
HLA in coeliac disease: unravelling the complex genetics of a complex disorder.
Tissue Antigens, 61 (2003), pp. 105-117
[16.]
G. Candore, D. Lio, G.C. Romano, C. Caruso.
Pathogenesis of autoimmune diseases associated with 8,1 ancestral haplotype: effect of multiple gene interactions.
Autoimmun Rev, 1 (2002), pp. 29-35
[17.]
I. Djilali-Saiah, J. Schmitz, E. Harfouch-Hammond, J.F. Mougenot, J.F. Bach, S. Caillat- Zucman.
CTLA-4 gene polymorphism is associated with predisposition to celiac disease.
Gut, 43 (1998), pp. 187-189
[18.]
R. McManus, A.G. Wilson, J. Mansfield, D.G. Weir, G.W. Duff, D. Kelleher.
TNF2, a polymorphism of the tumour necrosis-alpha gene promoter, is a component of the celiac disease major histocompatibility complex haplotype.
Eur J Immunol, 26 (1996), pp. 2113-2118
[19.]
E.G. De la Concha, M. Fernandez-Arquero, P. Vigil, A. Rubio, C. Maluenda, I. Polanco, et al.
Celiac disease and TNF promoter polymorphisms.
Hum Immunol, 61 (2000), pp. 513-517
[20.]
J.A. Garrote, E. Arranz, J.J. Telleria, J. Castro, C. Calvo, A. Blanco-Quiros.
TNFα and LTα gene polymorphisms as additional markers of celiac disease susceptibility in a DQ2-positive population.
Immunogenetics, 54 (2002), pp. 551-556
[21.]
A. Lopez-Vazquez, L. Rodrigo, D. Fuentes, S. Riestra, C. Bousono, S. Garcia-Fernandez, et al.
MHC class I chain related gene A (MICA) modulates the development of coeliac disease in patients with the high risk heterodimer DQA1*0501/DQB1*0201.
Gut, 50 (2002), pp. 336-340
[22.]
L. Fernandez, M. Fernandez-Arquero, L. Gual, F. Lazaro, C. Maluenda, I. Polanco, et al.
Triplet repeat polymorphism in the transmembrane region of the MICA gene in celiac disease.
Tissue Antigens, 59 (2002), pp. 219-222
[23.]
B. Rueda, M. Pascual, M.A. Lopez-nevot, B.P.C. Koeleman, E. Ortega, J. Maldonado, et al.
Association of MICA-A5.1 allele with susceptibility to celiac disease in a family study.
Am J Gastroenterol, 98 (2003), pp. 359-362
[24.]
M.A. Ramos-Arroyo, E. Feijoo, F. Sanchez-Valverde, E. Aranburu, N. Irisarri, J.E. Olivera, et al.
Heat-shock protein 70-1 and HLA class II gene polymorphisms associated with celiac disease susceptibility in Navarra (Spain).
Human Immunol, 62 (2001), pp. 821-825
[25.]
L. Greco, G. Corazza, M.C. Babron, F. Clot, M.C. Fulchignoni-Lataud, S. Percopo, et al.
Genome search in celiac disease.
Am J Hum Genet, 62 (1998), pp. 669-675
[26.]
A.L. King, J.Y. Yiannakou, P.M. Brett, D. Curtis, M.A. Morris, A.M. Dearlove, et al.
A genome-wide family-based linkage study of coeliac disease.
Am Hum Genet, 64 (2000), pp. 479-490
[27.]
M.C. Babron, S. Nilsson, S. Adamovic, A.T. Naluai, J. Wahlstrom, H. Ascher, et al.
Meta and pooled analysis of European celiac disease data.
Eur J Hum Genet, 11 (2003), pp. 828-834
[28.]
K. Kaukinen, J. Partanen, M. Maki, P. Collin.
HLA-DQ typing in the diagnosis of celiac disease.
Am J Gastroenterol, 97 (2002), pp. 695-699
Copyright © 2004. Elsevier España, S.L.. Todos los derechos reservados